Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01876303 · ClinicalTrials.gov registry record
Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma
A clinical trial of Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET), sponsored by Children's Oncology Group.
- Completed
- Registry status
- 1,650
- Enrollment target
- 1
- Study location
NCT01876303: Completed study of Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET), sponsored by Children's Oncology Group.
NCT01876303 is a study of Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET) that has completed, run by Children's Oncology Group. The registered enrollment target is 1,650 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01876303, a study of Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET), has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 1,650 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies genetic biomarkers from saliva samples in patients with Ewing sarcoma. Studying samples of saliva from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
Study Locations (1)
California
- Children's Oncology Group - Monrovia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,650 participants |
| Start Date | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01876303
The ClinicalTrials.gov registry entry for NCT01876303 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET) appearing as the primary indexed condition, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT01876303 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01876303 about?
NCT01876303 is a clinical study titled "Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma". This clinical trial studies genetic biomarkers from saliva samples in patients with Ewing sarcoma. Studying samples of saliva from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.
What is the current status of trial NCT01876303?
This trial is currently completed. The enrollment target is 1,650 participants. The study started on 2012-12.
What conditions does trial NCT01876303 study?
This clinical trial studies the following conditions: Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET).
What interventions are being tested in trial NCT01876303?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER).
Who is sponsoring clinical trial NCT01876303?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01876303 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.